argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease
October 8, 2026, 7:00 AM CET
Covered in this story
Call it yourself
No calls on $ARGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on argenx →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.